Neurotrophins in the pathogenesis and potential treatment of Parkinson's disease.
Bradford
H F
HF
Department of Biochemistry, Imperial College of Science, Technology and Medicine, South Kensington, London, United Kingdom.
Zhou
J
J
Pliego-Rivero
B
B
Stern
G M
GM
Jauniaux
E
E
D000818:Animals; D001921:Brain / Q000378:metabolism; D019208:Brain-Derived Neurotrophic Factor / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology; D004298:Dopamine / Q000494:pharmacology / Q000502:physiology; D006801:Humans; D009414:Nerve Growth Factors / Q000494:pharmacology / Q000502:physiology*; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D018696:Neuroprotective Agents / Q000494:pharmacology; D009498:Neurotoxins / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010300:Parkinson Disease / Q000188:drug therapy* / Q000209:etiology*
D019208:Brain-Derived Neurotrophic Factor; D009414:Nerve Growth Factors; D018696:Neuroprotective Agents; D009498:Neurotoxins; D004298:Dopamine